topic: Solution

Categories
more
Tags
ascoStrategic InsightsEthnographic Researchprecision medicineQuantitative Market ResearchRCCMarket Innovationnewsimmuno-oncologyMedTech & Diagnostics IndustriesPARP inhibitorsCOVID19

more
Current Posts
EU COVID-19 report cover
30.07.2020
Psyma Releases EU Survey Results on ...
US COVID-19 Impact Report
23.06.2020
Psyma Releases US Survey Results on ...
09.04.2020
It's Not Business As Usual
 more
Authors
Jill Salisbury
Vice President,
Psyma International Inc.
Elly Simmons
Vice President, Strategy & Insights,
Psyma International Inc.
James Roberts
Vice President,
Psyma International Inc.
 more
Stay informed
Contact
Corporate Headquarters
Rückersdorf bei Nürnberg>
PSYMA GROUP AG
Fliedersteig 15 - 17
90607 Rückersdorf / Nürnberg
Germany
CONTACT REQUEST
SHOW LOCATIONS
Imprint | Privacy policy
copyright © 2023 PSYMA GROUP AG